nisoxetine hydrochloride has been researched along with vestra in 1 studies
| Studies (nisoxetine hydrochloride) | Trials (nisoxetine hydrochloride) | Recent Studies (post-2010) (nisoxetine hydrochloride) | Studies (vestra) | Trials (vestra) | Recent Studies (post-2010) (vestra) |
|---|---|---|---|---|---|
| 11 | 0 | 3 | 10 | 0 | 9 |
| Protein | Taxonomy | nisoxetine hydrochloride (IC50) | vestra (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartog, PBR; Heitman, LH; IJzerman, AP; Maresca, G; Rossignoli, A; Scarabottolo, L; Sijben, HJ; Stucchi, L; van Oostveen, WM | 1 |
1 other study(ies) available for nisoxetine hydrochloride and vestra
| Article | Year |
|---|---|
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors.
Topics: Biosensing Techniques; Dopamine; Doxycycline; Epinephrine; Fluoxetine; High-Throughput Screening Assays; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Substrate Specificity | 2021 |